Clinical Trial Update: Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating a combination of lobaplatin, 5-fluorouracil, and leucovorin for esophageal cancer. The trial status is currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: Taian Cancer Hospital | Conditions: Esophageal Carcinoma | Phase 3 | Status: UNKNOWN